Procoralan® Receives European Approval for Use in Heart Failure SYS-CON Media (press release) Servier today announced that the company's heart rate lowering agent, ▼Procoralan® (ivabradine), the first selective I f channel inhibitor, has been approved by the European Commission for the treatment of patients with chronic heart failure. |
